NCT05544513Active, not recruitingPhase 2
Oral Iron Supplementation for Patients With Chronic Kidney Disease
Effects of Oral Iron Supplementation on Gut Microbiota in Patients With Chronic Kidney Disease
Source: ClinicalTrials.gov · Last updated 3 Apr 2025
Brief summary (registry, in English)
The hypothesis of this research is that oral iron prescribed in a single dose in alternate day could mitigate the side effects with regard to intestinal microbiota, inflammation, oxidative stress and improve the hematological profile when compared to daily oral iron prescription
- Status (registry)
- Active, not recruiting
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 6 (actual)
- First submitted
- 4 Jan 2022
- Start date
- 1 Aug 2022
- Primary completion date
- 29 Dec 2026
- Lead sponsor
- Universidade Federal Fluminense
- Diseases
- Chronic kidney disease
- NCT number
- NCT05544513
What you commit to
- Study type: Interventional · Phase 2
- Participants enrolled: 6
- From 1 Aug 2022 to the primary completion date, 29 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Autoimmune diseases
- Clinical diagnosis of infectious diseases
- Clinical diagnosis of Cancer
Other
- Patients pregnant
- Smokers
- Using antibiotics in the last 3 months
- Clinical diagnosis of AIDS
Who the study is looking for
- Aged 18 to 75 years Clinical diagnosis of Chronic Kidney Disease Conservative treatment group: chronic kidney disease stages 3 and 5
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Denise mafra Coordinator of this site? Confirm its status | Rio de Janeiro | Brazil | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.